Cours Respirerx Pharmaceuticals Inc OTC Bulletin Board
Actions
Recherche biotechnologique et médicale
Cours en clôture
Autres places de cotation
|
||
- USD | - |
|
CA 2021 | - | CA 2022 | - | Capitalisation | 289 k 259 k |
---|---|---|---|---|---|
Résultat net 2021 | -3 M -2,69 M | Résultat net 2022 | -2 M -1,79 M | VE / CA 2021 | - |
Dette nette 2021 | 2,08 M 1,86 M | Dette nette 2022 | 2,71 M 2,43 M | VE / CA 2022 | - |
PER 2021 |
-0,29
x | PER 2022 |
-0,06
x | Employés | - |
Rendement 2021 * |
-
| Rendement 2022 |
-
| Flottant | 93,37% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 22/03/13 |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 22/03/13 |
Richard Purcell
CTO | Chief Tech/Sci/R&D Officer | 63 | 15/10/14 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Arnold Lippa
CEO | Chief Executive Officer | 77 | 22/03/13 |
Director/Board Member | - | 22/03/23 | |
Jeff Margolis
DFI | Director of Finance/CFO | 68 | 22/03/13 |
Varia. 1 janv. | Capi. | |
---|---|---|
+16,49% | 122 Md | |
+21,73% | 115 Md | |
+22,10% | 26,64 Md | |
-21,81% | 19,91 Md | |
-16,89% | 16,32 Md | |
-18,81% | 15,49 Md | |
-44,74% | 15,52 Md | |
+62,72% | 14,83 Md | |
+3,09% | 13,67 Md |
- Bourse
- Actions
- Action RSPI
- Action